Zydus improves ESG rating to 68, up from 66 last year

The improved score reflects a stronger ESG profile for the Ahmedabad-based drugmaker

Cleveland Diagnostics’ IsoPSA test for prostate cancer detection gains FDA approval

Now a test that offers new precision in prostate cancer detection

PM addresses valedictory function of 9th World Ayurveda Congress

Expressed happiness that more than 30 countries of the world have given recognition to Ayurveda as a traditional system of medicine

Transforming Healthcare Through AI

NHS UK gives green light to a company to detect early-stage cancer by a simple blood test

Results from these studies are expected to be released by 2023. If outcomes from these initial pilots are positive, the studies will be expanded to involve around 1 million participants in 2024 and 2025